Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. [electronic resource]
Producer: 20190710Description: 814-824 p. digitalISSN:- 1546-170X
- Adult
- Aged
- Animals
- Antigen Presentation
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines
- Carboxymethylcellulose Sodium -- analogs & derivatives
- Cell Line, Tumor
- Combined Modality Therapy
- Dendritic Cells -- immunology
- Female
- Humans
- Immunotherapy, Adoptive
- Lymphoma, B-Cell -- immunology
- Male
- Membrane Proteins -- immunology
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Knockout
- Middle Aged
- Poly I-C -- therapeutic use
- Polylysine -- analogs & derivatives
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Toll-Like Receptor 3 -- agonists
- Vaccination
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.